Lactorel
Pharmacological chaperone indicated as a long-term oral treatment for adolescent and adult patients with a confirmed diagnosis of Fabry disease (α-galactosidase A deficiency) who carry amenable mutations.
Therapeutic Area
Rare Diseases
Active Ingredient
Migalastat
Line
Rare Diseases
Dosage Forms
123 mg x 14 hard capsules.
